NA
PBH icon

Navellier & Associates’s Prestige Consumer Healthcare PBH Stock Holding History

Navellier & Associates’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-5,488
Closed -$304K – 305
2016
Q2 		$304K Sell
5,488
-279
-5% -$15.4K 0.05% 177
2016
Q1 		$308K Sell
5,767
-229
-4% -$11.3K 0.04% 168
2015
Q4 		$309K Buy
+5,996
New +$298K 0.03% 167

Other funds holding PBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
MRCP
Manor Road Capital Partners New York $63.8M AUM 19.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Navellier & Associates's PBH Position: Q3 2016 in Review

Navellier & Associates sold out of Prestige Consumer Healthcare (PBH) in Q3 2016, closing a stake of 5,488 shares — an estimated $304K sold.

Navellier & Associates first reported a position in PBH in Q4 2015 and held it in 3 quarters. The position peaked at $309K in Q4 2015. 243 funds tracked by Wall St. Rank hold PBH as of Q3 2016.

  • Navellier & Associates reported no remaining Prestige Consumer Healthcare position as of Q3 2016 after selling out during the quarter.
  • Navellier & Associates sold 5,488 Prestige Consumer Healthcare shares in Q3 2016, an estimated $304K.
  • Navellier & Associates first reported a position in Prestige Consumer Healthcare in Q4 2015 and held it in 3 quarters.
  • Navellier & Associates's Prestige Consumer Healthcare position peaked at $309K in Q4 2015.
  • 243 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2016.

Based on Navellier & Associates's 13F filing for Q3 2016, filed 24 Oct 2016.